Systematic genomic identification of colorectal cancer genes delineating advanced from early clinical stage and metastasis

BMC Medical Genomics

Volumn 6, Issue 1, 2013, Pages

  Lee, Hojoon ^a   Flaherty, Patrick ^b   Ji, Hanlee P ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Worcester Polytechnic Institute   (United States)

Author keywords

Clinical stage; Colorectal cancer; Genetics; Genomics; Metastasis

Indexed keywords

MESSENGER RNA; MICRORNA;

ADRA2C GENE; ADVANCED CANCER; ARTICLE; BOOTSTRAPPING; CANCER STAGING; COLORECTAL CANCER; COPY NUMBER VARIATION; DATA ANALYSIS; DDX5 GENE; DISEASE ASSOCIATION; DNA METHYLATION; EARLY CANCER; GENE EXPRESSION; GENE IDENTIFICATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC DATABASE; GENETIC DISORDER; METASTASIS; PREDICTION; PRIORITY JOURNAL; SYK GENE; TUMOR GENE; WRN GENE;

COLORECTAL NEOPLASMS; GENETIC VARIATION; GENOMICS; HUMANS; INTERNET; MICROSATELLITE INSTABILITY; NEOPLASM METASTASIS; NEOPLASM STAGING; REGRESSION ANALYSIS;

EID: 84889016932     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-6-54     Document Type: Article

References (46)

1. Cancer Statistics, 2013. Siegel R, Naishadham D, Jemal A, CA Cancer J Clin 2013 63 11 30 10.3322/caac.21166 23335087
2. Cancer genes and the pathways they control. Vogelstein B, Kinzler KW, Nat Med 2004 10 789 799 10.1038/nm1087 15286780 (Pubitemid 39070849)
3. The genomic landscapes of human breast and colorectal cancers. Wood LD, Parsons DW, Jones S, Lin J, Sjöblom T, Leary RJ, Shen D, Boca SM, Barber T, Ptak J, Silliman N, Szabo S, Dezso Z, Ustyanksky V, Nikolskaya T, Nikolsky Y, Karchin R, Wilson PA, Kaminker JS, Zhang Z, Croshaw R, Willis J, Dawson D, Shipitsin M, Willson JKV, Sukumar S, Polyak K, Park BH, Pethiyagoda CL, Pant PVK, et al. Science 2007 318 1108 1113 10.1126/science.1145720 17932254 (Pubitemid 350134889)
4. The consensus coding sequences of human breast and colorectal cancers. Sjöblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, Szabo S, Buckhaults P, Farrell C, Meeh P, Markowitz SD, Willis J, Dawson D, Willson JKV, Gazdar AF, Hartigan J, Wu L, Liu C, Parmigiani G, Park BH, Bachman KE, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE, Science 2006 314 268 274 10.1126/science.1133427 16959974 (Pubitemid 44571966)
5. Molecular genetics of colorectal cancer. Fearon ER, Annu Rev Pathol 2011 6 479 507 10.1146/annurev-pathol-011110-130235 21090969
6. A genetic model for colorectal tumorigenesis. Fearon ER, Vogelstein B, Cell 1990 61 759 767 10.1016/0092-8674(90)90186-I 2188735 (Pubitemid 20185636)
7. Cancer genome landscapes. Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA, Kinzler KW, Science 2013 339 1546 1558 10.1126/science.1235122 23539594
8. COSMIC: mining complete cancer genomes in the catalogue of somatic mutations in cancer. Forbes S a, Bindal N, Bamford S, Cole C, Kok CY, Beare D, Jia M, Shepherd R, Leung K, Menzies A, Teague JW, Campbell PJ, Stratton MR, Futreal PA, Nucleic Acids Res 2011 39 Database issue 945 D950 20952405
9. Linking colorectal cancer to Wnt signaling. Bienz M, Clevers H, Cell 2000 103 311 320 10.1016/S0092-8674(00)00122-7 11057903
10. Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Shirasawa S, Furuse M, Yokoyama N, Sasazuki T, Science 1993 260 85 88 10.1126/science.8465203 8465203 (Pubitemid 23122749)
11. TGFBR1*6A and cancer: a meta-analysis of 12 case-control studies. Pasche B, Kaklamani V, Hou N, Young T, Rademaker A, Peterlongo P, Ellis N, Offit K, Caldes T, Reiss M, Zheng T, J Clin Oncol 2004 22 756 758 10.1200/JCO.2004.99.271 14966109
12. Molecular profiling and risk stratification of adenocarcinoma of the colon. Mutch MG, J Surg Oncol 2007 96 693 703 10.1002/jso.20915 18081153
13. Comprehensive molecular characterization of human colon and rectal cancer. Muzny DM, Bainbridge MN, Chang K, Dinh HH, Drummond J a, Fowler G, Kovar CL, Lewis LR, Morgan MB, Newsham IF, Reid JG, Santibanez J, Shinbrot E, Trevino LR, Wu YQ, Wang M, Gunaratne P, Donehower L a, Creighton CJ, Wheeler D a, Gibbs R a, Lawrence MS, Voet D, Jing R, Cibulskis K, Sivachenko A, Stojanov P, McKenna A, Lander ES, Gabriel S, et al. Nature 2012 487 330 337 10.1038/nature11252 22810696
14. Integrative clustering of multiple genomic data types using a joint latent variable model with application to breast and lung cancer subtype analysis. Shen R, Olshen AB, Ladanyi M, Bioinformatics 2009 25 2906 2912 10.1093/bioinformatics/btp543 19759197
15. Translating cancer "omics" to improved outcomes. Vucic EA, Thu KL, Robison K, Rybaczyk LA, Chari R, Alvarez CE, Lam WL, Genome Res 2012 22 188 195 10.1101/gr.124354.111 22301133
16. Making sense of cancer genomic data. Chin L, Hahn WC, Getz G, Meyerson M, Genes Dev 2011 25 534 555 10.1101/gad.2017311 21406553
17. The UCSC cancer genomics browser: update 2013. Goldman M, Craft B, Swatloski T, Ellrott K, Cline M, Diekhans M, Ma S, Wilks C, Stuart J, Haussler D, Zhu J, Nucleic Acids Res 2013 41 Database issue 949 D954 23109555
18. SelTarbase, a database of human mononucleotide-microsatellite mutations and their potential impact to tumorigenesis and immunology. Woerner SM, Yuan YP, Benner A, Korff S, von Knebel Doeberitz M, Bork P, Nucleic Acids Res 2010 38 Database issue 682 D689 19820113
19. Microsatellite instability in colorectal cancer-the stable evidence. Vilar E, Gruber SB, Nat Rev Clin Oncol 2010 7 153 162 10.1038/nrclinonc.2009.237 20142816
20. Genenames.org: the HGNC resources in 2013. Gray K, Daugherty LC, Gordon SM, Seal RL, Wright MW, Bruford E, Nucleic Acids Res 2013 41 Database issue 545 D552 23161694
21. I. T. Jolliffe, Principal Component Analysis (Springer Series in Statistics) New York: Springer 2 2002
22. Significance analysis of microarrays applied to the ionizing radiation response. Tusher VG, Tibshirani R, Chu G, Proc Natl Acad Sci U S A 2001 98 5116 5121 10.1073/pnas.091062498 11309499 (Pubitemid 32397092)
23. Regularization and variable selection via the elastic net. Zou H, Hastie T, J R Stat Soc Ser B (Statistical Methodol 2005 67 301 320 10.1111/j.1467-9868. 2005.00503.x (Pubitemid 40465877)
24. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Chin K, DeVries S, Fridlyand J, Spellman PT, Roydasgupta R, Kuo W-L, Lapuk A, Neve RM, Qian Z, Ryder T, Chen F, Feiler H, Tokuyasu T, Kingsley C, Dairkee S, Meng Z, Chew K, Pinkel D, Jain A, Ljung BM, Esserman L, Albertson DG, Waldman FM, Gray JW, Cancer Cell 2006 10 529 541 10.1016/j.ccr.2006.10.009 17157792 (Pubitemid 44854748)
25. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Curtis C, Shah SP, Chin S-F, Turashvili G, Rueda OM, Dunning MJ, Speed D, Lynch AG, Samarajiwa S, Yuan Y, Graf S, Ha G, Haffari G, Bashashati A, Russell R, McKinney S, Langerod A, Green A, Provenzano E, Wishart G, Pinder S, Watson P, Markowetz F, Murphy L, Ellis I, Purushotham A, Borresen-Dale A-L, Brenton JD, Tavare S, Caldas C, et al. Nature 2012 486 346 352 22522925
26. Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. Shen L, Toyota M, Kondo Y, Lin E, Zhang L, Guo Y, Hernandez NS, Chen X, Ahmed S, Konishi K, Hamilton SR, Issa J-PJ, Proc Natl Acad Sci U S A 2007 104 18654 18659 10.1073/pnas.0704652104 18003927 (Pubitemid 350210752)
27. Pattern discovery and cancer gene identification in integrated cancer genomic data. Mo Q, Wang S, Seshan VE, Olshen AB, Schultz N, Sander C, Powers RS, Ladanyi M, Shen R, Proc Natl Acad Sci U S A 2013 110 4245 4250 10.1073/pnas.1208949110 23431203
28. Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signaling. Kristensen VN, Vaske CJ, Ursini-Siegel J, Van Loo P, Nordgard SH, Sachidanandam R, Sørlie T, Wärnberg F, Haakensen VD, Helland Å Naume B, Perou CM, Haussler D, Troyanskaya OG, Børresen-Dale A-L, Proc Natl Acad Sci U S A 2012 109 2802 2807 10.1073/pnas.1108781108 21908711
29. Integrating multiple evidence sources to predict transcription factor binding in the human genome. Ernst J, Plasterer HL, Simon I, Bar-Joseph Z, Genome Res 2010 20 526 536 10.1101/gr.096305.109 20219943
30. Davison AC, Hinkley DV, Bootstrap Methods and Their Application Cambridge: Cambridge University Press 1997
31. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Cancer T, Atlas G, Nature 2008 455 1061 1068 10.1038/nature07385 18772890
32. IDH1 and IDH2 mutations in gliomas. Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ, Friedman H, Friedman A, Reardon D, Herndon J, Kinzler KW, Velculescu VE, Vogelstein B, Bigner DD, N Engl J Med 2009 360 765 773 10.1056/NEJMoa0808710 19228619
33. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B, Science 1995 268 1336 1338 10.1126/science.7761852 7761852
34. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Kane MF, Loda M, Gaida GM, Lipman J, Mishra R, Goldman H, Jessup JM, Kolodner R, Cancer Res 1997 57 808 811 9041175 (Pubitemid 27097998)
35. Two novel regions of interstitial deletion on chromosome 8p in colorectal cancer. Chughtai SA, Crundwell MC, Cruickshank NR, Affie E, Armstrong S, Knowles MA, Takle LA, Kuo M, Khan N, Phillips SM, Neoptolemos JP, Morton DG, Oncogene 1999 18 657 665 10.1038/sj.onc.1202340 9989816 (Pubitemid 29080323)
36. WRN promoter methylation possibly connects mucinous differentiation, microsatellite instability and CpG island methylator phenotype in colorectal cancer. Kawasaki T, Ohnishi M, Suemoto Y, Kirkner GJ, Liu Z, Yamamoto H, Loda M, Fuchs CS, Ogino S, Mod Pathol 2008 21 150 158 18084250 (Pubitemid 351172166)
37. Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer. Agrelo R, Cheng W-H, Setien F, Ropero S, Espada J, Fraga MF, Herranz M, Paz MF, Sanchez-Cespedes M, Artiga MJ, Guerrero D, Castells A, von Kobbe C, Bohr VA, Esteller M, Proc Natl Acad Sci U S A 2006 103 8822 8827 10.1073/pnas.0600645103 16723399 (Pubitemid 43878103)
38. The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells. Coopman PJ, Do MT, Barth M, Bowden ET, Hayes AJ, Basyuk E, Blancato JK, Vezza PR, McLeskey SW, Mangeat PH, Mueller SC, Nature 2000 406 742 747 10.1038/35021086 10963601
39. Plasma miR-21: a potential diagnostic marker of colorectal cancer. Kanaan Z, Rai SN, Eichenberger MR, Roberts H, Keskey B, Pan J, Galandiuk S, Ann Surg 2012 256 544 551 10.1097/SLA.0b013e318265bd6f 22868372
40. Mo Y-Y: miR-21-mediated tumor growth. Si M-L, Zhu S, Wu H, Lu Z, Wu F, Oncogene 2007 26 2799 2803 10.1038/sj.onc.1210083 17072344 (Pubitemid 46663837)
41. Yamamoto K, Imakiire A, Miyagawa N, Kasahara T, A report of two cases of Werner' s syndrome and review of the literature. 2003 11 224 233
42. RecQ helicases: Caretakers of the genome. Hickson ID, Nat Rev Cancer 2003 3 169 178 10.1038/nrc1012 12612652 (Pubitemid 37328869)
43. Werner's syndrome a review of its symptomatology, natural history, pathologic features, genetics and relationship to the natural aging process. Epstein CJ, Martin GM, Schultz AL, Motulsky AG, Medicine (Baltimore) 1966 45 177 221 5327241
44. Recurrent hemizygous deletions in cancers may optimize proliferative potential. Solimini NL, Xu Q, Mermel CH, Liang AC, Schlabach MR, Luo J, Burrows AE, Anselmo AN, Bredemeyer AL, Li MZ, Beroukhim R, Meyerson M, Elledge SJ, Science 2012 337 104 109 10.1126/science.1219580 22628553
45. Prognostic factors in colorectal cancer. Compton CC, Fielding LP, Burgart LJ, Conley B, Cooper HS, Hamilton SR, Hammond MEH, Henson DE, Hutter RVP, Nagle RB, Nielsen ML, Sargent DJ, Taylor CR, Welton M, Willett C, Arch Pathol Lab Med 2000 124 979 994 10888773
46. Prediction of metastasis and recurrence in colorectal cancer based on gene expression analysis: Ready for the clinic? Cancers (Basel)2011 3 2858-2869 10.3390/cancers3032858 24212936 Shibayama M.,Maak M.,Nitsche U.